Literature DB >> 21366553

Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2.

J Gan1, S M Greenwood, S R Cobb, T J Bushell.   

Abstract

BACKGROUND AND
PURPOSE: Proteinase-activated receptor-2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation modulates synaptic activity in the hippocampus. EXPERIMENTAL APPROACH: PAR2 activation and its effect on the hippocampus were examined in rat primary cultures and acute slices using whole cell patch clamp and standard extracellular recordings, respectively. KEY
RESULTS: PAR2 activation leads to a depolarization of hippocampal neurones and a paradoxical reduction in the occurrence of synaptically driven spontaneous action potentials (APs). PAR2-induced neuronal depolarization was abolished following either the inhibition of astrocytic function or antagonism of ionotropic glutamate receptors whilst the PAR2-induced decrease in AP frequency was also reduced when astrocytic function was inhibited. Furthermore, when examined in acute hippocampal slices, PAR2 activation induced a profound long-term depression of synaptic transmission that was dependent on NMDA receptor activation and was sensitive to disruption of astrocytic function. CONCLUSIONS AND IMPLICATIONS: These novel findings show that PAR2 activation indirectly inhibits hippocampal synaptic activity and indicate that these receptors may play an active role in modulating normal physiological CNS function, in addition to their role in pathophysiological disorders.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366553      PMCID: PMC3130945          DOI: 10.1111/j.1476-5381.2011.01293.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression.

Authors:  Jing-ming Zhang; Hui-kun Wang; Chang-quan Ye; Wooping Ge; Yiren Chen; Zheng-lin Jiang; Chien-ping Wu; Mu-ming Poo; Shumin Duan
Journal:  Neuron       Date:  2003-12-04       Impact factor: 17.173

Review 2.  Protease-activated receptors: contribution to physiology and disease.

Authors:  Valeria S Ossovskaya; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

Review 3.  Use of fluorocitrate and fluoroacetate in the study of brain metabolism.

Authors:  F Fonnum; A Johnsen; B Hassel
Journal:  Glia       Date:  1997-09       Impact factor: 7.452

4.  Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia.

Authors:  F Striggow; M Riek-Burchardt; A Kiesel; W Schmidt; P Henrich-Noack; J Breder; M Krug; K G Reymann; G Reiser
Journal:  Eur J Neurosci       Date:  2001-08       Impact factor: 3.386

5.  Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection.

Authors:  Farshid Noorbakhsh; Nathalie Vergnolle; Justin C McArthur; Claudia Silva; Mohammed Vodjgani; Patricia Andrade-Gordon; Morley D Hollenberg; Christopher Power
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

6.  Plasticity-related regulation of the hippocampal proteome.

Authors:  Kara McNair; Ceri H Davies; Stuart R Cobb
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

7.  Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues.

Authors:  M R D'Andrea; C K Derian; D Leturcq; S M Baker; A Brunmark; P Ling; A L Darrow; R J Santulli; L F Brass; P Andrade-Gordon
Journal:  J Histochem Cytochem       Date:  1998-02       Impact factor: 2.479

8.  Astrocytic activation and an inhibition of MAP kinases are required for proteinase-activated receptor-2-mediated protection from neurotoxicity.

Authors:  Sam M Greenwood; Trevor J Bushell
Journal:  J Neurochem       Date:  2010-04-06       Impact factor: 5.372

9.  Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors.

Authors:  M Riek-Burchardt; F Striggow; P Henrich-Noack; G Reiser; K G Reymann
Journal:  Neurosci Lett       Date:  2002-08-30       Impact factor: 3.046

10.  Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.

Authors:  J J Ubl; C Vöhringer; G Reiser
Journal:  Neuroscience       Date:  1998-09       Impact factor: 3.590

View more
  17 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Astrocyte origin of activity-dependent release of ATP and glutamate in hippocampal slices: real-time measurement utilizing microelectrode biosensors.

Authors:  Henry Sershen
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

4.  Novel animal models of acute and chronic cancer pain: a pivotal role for PAR2.

Authors:  David K Lam; Dongmin Dang; Jianan Zhang; John C Dolan; Brian L Schmidt
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

5.  Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory.

Authors:  Nor Zaihana Abdul Rahman; Sam M Greenwood; Ros R Brett; Kyoko Tossell; Mark A Ungless; Robin Plevin; Trevor J Bushell
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

6.  Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons.

Authors:  Louise Ritchie; Rothwell Tate; Luke H Chamberlain; Graham Robertson; Michele Zagnoni; Teresa Sposito; Selina Wray; John A Wright; Clare E Bryant; Nicholas J Gay; Trevor J Bushell
Journal:  Neuropharmacology       Date:  2018-03-02       Impact factor: 5.273

Review 7.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

8.  Activation of protease-activated receptor 2-mediated signaling by mast cell tryptase modulates cytokine production in primary cultured astrocytes.

Authors:  Xiaoning Zeng; Shu Zhang; Luwei Xu; Haiwei Yang; Shaoheng He
Journal:  Mediators Inflamm       Date:  2013-06-02       Impact factor: 4.711

Review 9.  Diverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitability.

Authors:  Tomasz Wójtowicz; Patrycja Brzdąk; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2015-08-10       Impact factor: 5.505

10.  Widefield Two-Photon Excitation without Scanning: Live Cell Microscopy with High Time Resolution and Low Photo-Bleaching.

Authors:  Rumelo Amor; Alison McDonald; Johanna Trägårdh; Gillian Robb; Louise Wilson; Nor Zaihana Abdul Rahman; John Dempster; William Bradshaw Amos; Trevor J Bushell; Gail McConnell
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.